This is a non-invasive option that naturally supports your body's own GLP-1 production
Do you offer this treatment or anything similar in clinic

RESEARCH AREAS Estrogen-related receptor alpha (ERR) agonism and receptor binding characterization Transcriptional regulation of mitochondrial biogenesis pathways (e.g., PGC-1 coactivation networks) Oxidative phosphorylation and fatty-acid oxidation gene-expression signaling Cellular energy-metabolism and substrate-utilization pathway modeling WHAT RESEARCHERS LOOK AT Receptor-binding and reporter-gene assays measuring ERR isoform engagement Dose-response transcriptional profiling of metabolic target genes in cell culture Mitochondrial density and respiration assays in isolated model systems Pathway-selectivity and off-target screening across nuclear-receptor panels QUICK SPECS Form: Capsule not for ingestion Net per capsule: 100mcg Count: 100 capsules per bottle Purity: 98% (HPLC) Identity: Confirmed by HPLC/MS Storage: Store sealed, cool, dry, protected from light IDENTITY BASICS Type: Synthetic small-molecule ERR agonist (non-peptide) Molecular formula: CHNO Molecular weight: ~445.5 g/mol CAS: 2231747-31-0 SELECTED RESEARCH PubChem: SLU-PP-332 compound record PubMed: SLU-PP-332 literature index PubMed: ERR agonist research PubMed: ERR/mitochondrial biogenesis signaling DISCLAIMER For laboratory and in vitro research use only

The peptide has also been studied in the context of retinal degeneration, where it showed protective effects on retinal pigment epithelium in models of age-related macular degeneration
Zepbound Tirzepatide Injection Prefilled Syringes 2.5 mg/0.5 mL are available by prescription only and should be used as directed by a healthcare provider. They should not be used to treat type 1 diabetes or diabetic ketoacidosis. Some possible side effects of this medication may include nausea, vomiting, diarrhea, discomfort at the injection site, and decreased appetite